Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference
SAN MATEO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company ...
USA Today18d
Which foods are considered 'healthy?' FDA issues new label criteria
"We know food labeling can be a powerful tool for change," James Jones, the FDA's deputy commissioner for human foods, said in a news conference. The goal, he said, is to "help consumers find ...
Accounts posing as Malaysian health ministry promote unauthorised joint pain medicine
The Malaysian health ministry says Facebook posts promoting a gel to treat bone and joint pains are "fake" and the accounts ...
Which foods are considered 'healthy?' FDA issues new label criteria
The Food and Drug Administration's new rules on "healthy" food labels are voluntary and are scheduled to take effect at the ...
Furman visits Pelote and Western Carolina
Western Carolina hosts the Furman Paladins after Bernard Pelote scored 24 points in Western Carolina's 78-69 victory over the Milligan Buffs.
Sporting News on MSN3d
Warriors may part with star wing duo in trade for age-defying $194 million Suns stud
“While they’d (Warriors) likely have to give up their young rising star Jonathan Kuminga, as well as former All-Star Andrew ...
The Brighterside of News on MSN6d
FDA approved drug achieves 100% remission for rectal cancer
The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...
Holloway, No. 5 Alabama overwhelm South Dakota State with 19 3-pointers in 105-82 victory
Aden Holloway made eight 3-pointers and scored 26 points off the bench, and No. 5 Alabama overwhelmed South Dakota State with 19 made 3-pointers in a ...
uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease
U.S. Food and Drug Administration (FDA) agrees that data from ongoing Phase I/II studies compared to a natural history external control may ...
Business Insider28d
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse Glioma Submission Plan Follows Productive and Collaborative Pre-NDA Interactions with FDA Company to Host Conference Call on ...
Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025
Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a company overview at the 43rd Annual J ...